Full Press Release Details
IDEAYA Reports Darovasertib IDE196 Monotherapy Overall Survival Data and Observes Early Partial Responses in Binimetinib Combination in Metastatic Uveal Melanoma.
IDYA
IDEAYA Reports Darovasertib IDE196 Monotherapy Overall Survival Data and Observes Early Partial Responses in Binimetinib Combination in Metastatic Uveal Melanoma
Key Takeaway: IDEAYA Reports Darovasertib IDE196 Monotherapy Overall Survival Data and Observes Early Partial Responses in Binimetinib Combination in Metastatic Uveal Melanoma